News

Yale researchers say that nasal application of neomycin shows promise in the prevention and treatment of respiratory viral infections.

Plant-derived nanoparticles, including those from rice bran, could be used as alternatives to traditional cancer treatments.

A new study has found that aspirin may help to prevent the development and progression of colorectal cancer by boosting certain aspects of the body’s immune response against cancer cells.

Traumatic brain injuries come with an amplified risk for developing dementia, but a new therapeutic target and a potential immunotherapy have been identified.

A new study offers an explanation and suggests a more effective approach to treatment of epilepsy. They found a previously overlooked region of the hippocampus, the fasciola cinereum, appears to be involved in instigating and propagating seizures.

In a first-of-its-kind clinical trial, researchers found that intravenous therapies made from virus-specific T-cells (VST) can effectively treat immunocompromised pediatric patients, far surpassing the current standard of care.

Two siblings who have the only known mutations in a key gene anywhere in the world have helped scientists gain new insights that could help progress the search for new treatments in type 1 diabetes.

Recently approved Alzheimer's drugs work by tagging amyloid plaques for clearance by the brain's microglia. Washington University School of Medicine in St. Louis researchers are developing an alternative approach, using a homemade antibody to directly mobilize microglia.

For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.

Salk scientists observe cannabinol's neuroprotective properties in fruit flies and identify cannabinol analogs that could serve as promising future therapeutics for traumatic brain injury, Alzheimer's, and Parkinson's.